Evidence map›Paper›PMID 36918495›Full record

ArticleCardiology and therapy2023

Correction to: Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i.

Erin S Mackinnon, Bryan Har, Salimah Champsi, Rajvi J Wani, Lee Geyer, Eileen Shaw, Megan S Farris, Todd J Anderson

Abstract readPublished Erratum
In one paragraph

Article in Cardiology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Erin S MackinnonAmgen Canada Inc., 6775 Financial Dr #100, Mississauga, ON, L5N 0A4, Canada. emackinn@amgen.com.ORCID https://orcid.org/0000-0001-9736-6970
Bryan HarLibin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID https://orcid.org/0000-0003-2760-8967
Salimah ChampsiAmgen Canada Inc., 6775 Financial Dr #100, Mississauga, ON, L5N 0A4, Canada.ORCID https://orcid.org/0000-0001-6205-6059
Rajvi J WaniAmgen Canada Inc., 6775 Financial Dr #100, Mississauga, ON, L5N 0A4, Canada.ORCID https://orcid.org/0000-0002-2422-7758
Lee GeyerMedlior Health Outcomes Research Ltd., Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-3805-5483
Eileen ShawMedlior Health Outcomes Research Ltd., Calgary, AB, Canada.ORCID https://orcid.org/0000-0001-6537-1898
Megan S FarrisMedlior Health Outcomes Research Ltd., Calgary, AB, Canada.ORCID https://orcid.org/0000-0003-0640-9512
Todd J AndersonLibin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID https://orcid.org/0000-0003-3751-6468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36918495
PMCPMC10209353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.